MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma

Abstract Dendritic cells (DC) are key players in antitumor immune responses. Tumors exploit their plasticity to escape immune control; their aberrant surface carbohydrate patterns (e.g., glycans) shape immune responses through lectin binding, and manipulate the metabolism of immune cells, including...

Full description

Saved in:
Bibliographic Details
Main Authors: Camille Niveau, Mélanie Cettour-Cave, Stéphane Mouret, Eleonora Sosa Cuevas, Mylene Pezet, Benoît Roubinet, Hugo Gil, Florence De Fraipont, Ludovic Landemarre, Julie Charles, Philippe Saas, Caroline Aspord
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-56392-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571540039794688
author Camille Niveau
Mélanie Cettour-Cave
Stéphane Mouret
Eleonora Sosa Cuevas
Mylene Pezet
Benoît Roubinet
Hugo Gil
Florence De Fraipont
Ludovic Landemarre
Julie Charles
Philippe Saas
Caroline Aspord
author_facet Camille Niveau
Mélanie Cettour-Cave
Stéphane Mouret
Eleonora Sosa Cuevas
Mylene Pezet
Benoît Roubinet
Hugo Gil
Florence De Fraipont
Ludovic Landemarre
Julie Charles
Philippe Saas
Caroline Aspord
author_sort Camille Niveau
collection DOAJ
description Abstract Dendritic cells (DC) are key players in antitumor immune responses. Tumors exploit their plasticity to escape immune control; their aberrant surface carbohydrate patterns (e.g., glycans) shape immune responses through lectin binding, and manipulate the metabolism of immune cells, including DCs to alter their function and escape immune surveillance. DC metabolic reprogramming could induce immune subversion and tumor immune escape. Here we explore metabolic features of human DC subsets (cDC2s, cDC1s, pDCs) in melanoma, at single cell level, using the flow cytometry-based SCENITH (Single-Cell ENergetIc metabolism by profiling Translation inHibition) method. We demonstrate that circulating and tumor-infiltrating DC subsets from melanoma patients are characterized by altered metabolism, which is linked to their activation status and profile of immune checkpoint expression. This altered metabolism influences their function and affects patient clinical outcome. Notably, melanoma tumor cells directly remodel the metabolic profile of DC subsets, in a glycan-dependent manner. Strikingly, modulation of the mTOR/AMPK-dependent metabolic pathways and/or the MCT1 lactate transporter rescue cDC2s and cDC1s from skewing by tumor-derived glycans, Sialyl-Tn antigen and Fucose, and restore anti-tumor T-cell fitness. Our findings thus open the way for appropriate tuning of metabolic pathways to rescue DCs from tumor hijacking and restore potent antitumor responses.
format Article
id doaj-art-b22e701bc7fe44f1a6c1942a4ae53c12
institution Kabale University
issn 2041-1723
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-b22e701bc7fe44f1a6c1942a4ae53c122025-02-02T12:32:14ZengNature PortfolioNature Communications2041-17232025-01-0116112410.1038/s41467-025-56392-xMCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanomaCamille Niveau0Mélanie Cettour-Cave1Stéphane Mouret2Eleonora Sosa Cuevas3Mylene Pezet4Benoît Roubinet5Hugo Gil6Florence De Fraipont7Ludovic Landemarre8Julie Charles9Philippe Saas10Caroline Aspord11Institute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble AlpesInstitute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble AlpesDermatology, Allergology & Photobiology Department, Univ. Grenoble Alpes, CHU Grenoble AlpesInstitute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble AlpesOptical Microscopy and Flow Cytometry (MicroCell), Institute for Advanced Biosciences, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble AlpesGLYcoDiagDepartment of Anatomopathology, Grenoble Alpes University Hospital CenterMedical Unit of Molecular genetic (hereditary diseases and oncology), Grenoble University HospitalGLYcoDiagDermatology, Allergology & Photobiology Department, Univ. Grenoble Alpes, CHU Grenoble AlpesInstitute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble AlpesInstitute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble AlpesAbstract Dendritic cells (DC) are key players in antitumor immune responses. Tumors exploit their plasticity to escape immune control; their aberrant surface carbohydrate patterns (e.g., glycans) shape immune responses through lectin binding, and manipulate the metabolism of immune cells, including DCs to alter their function and escape immune surveillance. DC metabolic reprogramming could induce immune subversion and tumor immune escape. Here we explore metabolic features of human DC subsets (cDC2s, cDC1s, pDCs) in melanoma, at single cell level, using the flow cytometry-based SCENITH (Single-Cell ENergetIc metabolism by profiling Translation inHibition) method. We demonstrate that circulating and tumor-infiltrating DC subsets from melanoma patients are characterized by altered metabolism, which is linked to their activation status and profile of immune checkpoint expression. This altered metabolism influences their function and affects patient clinical outcome. Notably, melanoma tumor cells directly remodel the metabolic profile of DC subsets, in a glycan-dependent manner. Strikingly, modulation of the mTOR/AMPK-dependent metabolic pathways and/or the MCT1 lactate transporter rescue cDC2s and cDC1s from skewing by tumor-derived glycans, Sialyl-Tn antigen and Fucose, and restore anti-tumor T-cell fitness. Our findings thus open the way for appropriate tuning of metabolic pathways to rescue DCs from tumor hijacking and restore potent antitumor responses.https://doi.org/10.1038/s41467-025-56392-x
spellingShingle Camille Niveau
Mélanie Cettour-Cave
Stéphane Mouret
Eleonora Sosa Cuevas
Mylene Pezet
Benoît Roubinet
Hugo Gil
Florence De Fraipont
Ludovic Landemarre
Julie Charles
Philippe Saas
Caroline Aspord
MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
Nature Communications
title MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
title_full MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
title_fullStr MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
title_full_unstemmed MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
title_short MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
title_sort mct1 lactate transporter blockade re invigorates anti tumor immunity through metabolic rewiring of dendritic cells in melanoma
url https://doi.org/10.1038/s41467-025-56392-x
work_keys_str_mv AT camilleniveau mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma
AT melaniecettourcave mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma
AT stephanemouret mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma
AT eleonorasosacuevas mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma
AT mylenepezet mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma
AT benoitroubinet mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma
AT hugogil mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma
AT florencedefraipont mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma
AT ludoviclandemarre mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma
AT juliecharles mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma
AT philippesaas mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma
AT carolineaspord mct1lactatetransporterblockadereinvigoratesantitumorimmunitythroughmetabolicrewiringofdendriticcellsinmelanoma